A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE2
Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations
- Status
- SUSPENDED
- Phase
- PHASE2
TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
- Status
- RECRUITING
- Phase
- PHASE1
Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry
- Status
- RECRUITING
- Phase
- N/A
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
- Status
- RECRUITING
- Phase
- PHASE2
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE1
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
- Status
- RECRUITING
- Phase
- PHASE2
Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
- Status
- RECRUITING
- Phase
- PHASE2
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Vitamin A and D Supplementation in Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE2
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Status
- RECRUITING
- Phase
- PHASE3
HEME Home Transfusion Program
- Status
- RECRUITING
- Phase
- NA
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
- Status
- RECRUITING
- Phase
- PHASE2